{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:26:20Z","timestamp":1794947180500,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Robot-assisted radical prostatectomy (RARP) rates have been increasing worldwide despite a lack of evidence of superior patient-reported outcomes (PROs) compared to open radical prostatectomy (ORP).\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective study included men who contributed data to the Prostate Cancer Outcomes Registry-Victoria (PCOR-Vic), underwent ORP or RARP between January 2014 and May 2018, and completed the EPIC-26 questionnaire 12\u00a0months post-surgery. Urinary and sexual bother items, the urinary incontinence domain score, the urinary irritative\/obstructive domain score, the sexual domain score and the pad usage item from the EPIC-26 questionnaire were compared between the two cohorts. Unmatched and propensity score matched cohorts were used to determine if there were differences in urinary and sexual PROs between ORP and RARP after accounting for the patient case-mix and surgeon characteristics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 3826 patients undergoing radical prostatectomy (RP), 1047 received ORP and 2779 received RARP. Propensity score matching reduced the magnitude of the observed differences in four out of six outcomes (urinary bother, urinary incontinence domain, pad usage\u00a0and sexual domain). Using a propensity score matched cohort, there were no statistically significant differences for RARP patients, compared to ORP patients, in terms of urinary bother (Rd\u2009=\u20090.47%, <jats:italic>P<\/jats:italic>\u2009=\u20090.707), urinary incontinence domain scores (Coeff\u2009=\u2009\u2212\u20090.84, <jats:italic>P<\/jats:italic>\u2009=\u20090.506), urinary irritative\/obstructive domain scores (Coeff\u2009=\u20091.03, <jats:italic>P<\/jats:italic>\u2009=\u20090.105), pad usage (Rd\u2009=\u2009\u2212\u20090.75%, <jats:italic>P<\/jats:italic>\u2009=\u20090.771) and sexual bother (Rd\u2009=\u2009\u2212\u20090.89%, <jats:italic>P<\/jats:italic>\u2009=\u20090.731). RARP patients had slightly higher sexual domain scores (Coeff\u2009=\u20093.65, <jats:italic>P<\/jats:italic>\u2009=\u20090.005).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>There were no differences in urinary PROs between ORP and RARP when assessed 12\u00a0months post-surgery. The sexual domain slightly favoured RARP, however this was not deemed clinically significant.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12894-022-00966-0","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T19:03:57Z","timestamp":1644260637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparison of urinary and sexual patient-reported outcomes between open radical prostatectomy and robot-assisted radical prostatectomy: a propensity score matched, population-based study in Victoria"],"prefix":"10.1186","volume":"22","author":[{"given":"Michael","family":"Rechtman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy L.","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lachlan","family":"Dodds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan G.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue M.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"issue":"10","key":"966_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.5694\/mja17.00559","volume":"208","author":"MA Evans","year":"2018","unstructured":"Evans MA, Millar JL, Earnest A, Frydenberg M, Davis ID, Murphy DG, et al. Active surveillance of men with low risk prostate cancer: evidence from the Prostate Cancer Outcomes Registry-Victoria. Med J Aust. 2018;208(10):443.","journal-title":"Med J Aust"},{"issue":"6","key":"966_CR2","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/bju.13317","volume":"117","author":"M Basto","year":"2016","unstructured":"Basto M, Sathianathen N, Marvelde L, Ryan S, Goad J, Lawrentschuk N, et al. Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system. BJU Int. 2016;117(6):930\u20139.","journal-title":"BJU Int"},{"issue":"10","key":"966_CR3","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/ans.14722","volume":"88","author":"LL Wang","year":"2018","unstructured":"Wang LL, Begashaw K, Evans M, Earnest A, Evans SM, Millar JL, et al. Patterns of care and outcomes for men diagnosed with prostate cancer in Victoria: an update. ANZ J Surg. 2018;88(10):1042.","journal-title":"ANZ J Surg"},{"issue":"2","key":"966_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79(2):243\u201362.","journal-title":"Eur Urol"},{"issue":"3","key":"966_CR5","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.juro.2017.11.095","volume":"199","author":"MG Sanda","year":"2018","unstructured":"Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, et al. Clinically localized prostate cancer: AUA\/ASTRO\/SUO guideline. Part I: risk stratification, shared decision making, and care options. J Urol. 2018;199(3):683\u201390.","journal-title":"J Urol"},{"issue":"8","key":"966_CR6","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S1470-2045(18)30357-7","volume":"19","author":"GD Coughlin","year":"2018","unstructured":"Coughlin GD, Yaxley JW, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncol. 2018;19(8):1051\u201360.","journal-title":"Lancet Oncol"},{"issue":"10049","key":"966_CR7","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0140-6736(16)30592-X","volume":"388","author":"JW Yaxley","year":"2016","unstructured":"Yaxley JW, Coughlin GD, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. The Lancet. 2016;388(10049):1057\u201366.","journal-title":"The Lancet"},{"issue":"1","key":"966_CR8","first-page":"35","volume":"12","author":"J Finkelstein","year":"2010","unstructured":"Finkelstein J, Eckersberger E, Sadri H, Taneja SS, Lepor H, Djavan B. Open versus laparoscopic versus robot-assisted laparoscopic prostatectomy: the European and US experience. Rev Urol. 2010;12(1):35\u201343.","journal-title":"Rev Urol"},{"issue":"11","key":"966_CR9","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S1470-2045(17)30572-7","volume":"18","author":"A Aggarwal","year":"2017","unstructured":"Aggarwal A, Lewis D, Mason M, Purushotham A, Sullivan R, van der Meulen J. Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study. Lancet Oncol. 2017;18(11):1445\u201353.","journal-title":"Lancet Oncol"},{"issue":"3","key":"966_CR10","first-page":"173","volume":"39","author":"M Frydenberg","year":"2015","unstructured":"Frydenberg M, Murphy DG, Moon DA, Lawrentschuk N. Robotic assisted radical prostatectomy versus open retropubic radical prostatectomy: Where do we stand in 2015? Cancer Forum. 2015;39(3):173\u20137.","journal-title":"Cancer Forum"},{"issue":"1","key":"966_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000447495","volume":"98","author":"J Schiffmann","year":"2017","unstructured":"Schiffmann J, Larcher A, Sun M, Tian Z, Berdugo J, Leva I, et al. Differences in patient characteristics among men choosing open or robot-assisted radical prostatectomy in contemporary practice\u2014analysis of surveillance, epidemiology, and end results database. Urol Int. 2017;98(1):48.","journal-title":"Urol Int"},{"issue":"1","key":"966_CR12","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.21037\/tau.2017.12.20","volume":"7","author":"T Chandrasekar","year":"2018","unstructured":"Chandrasekar T, Tilki R. Robotic-assisted vs open radical prostatectomy: an update to the never-ending debate. Transl Androl Urol. 2018;7(1):S120\u20133.","journal-title":"Transl Androl Urol"},{"issue":"6","key":"966_CR13","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.eururo.2015.05.046","volume":"69","author":"G Gandaglia","year":"2016","unstructured":"Gandaglia G, Bray F, Cooperberg MR, Karnes RJ, Leveridge MJ, Moretti K, et al. Prostate cancer registries: current status and future directions. Eur Urol. 2016;69(6):998\u20131012.","journal-title":"Eur Urol"},{"issue":"2","key":"966_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.euf.2015.06.011","volume":"2","author":"B Gershman","year":"2016","unstructured":"Gershman B, Psutka SP, McGovern FJ, Dahl DM, Tabatabaei S, Gettman MT, et al. Patient-reported functional outcomes following open, laparoscopic, and robotic assisted radical prostatectomy performed by high-volume surgeons at high-volume hospitals. Eur Urol Focus. 2016;2(2):172\u20139.","journal-title":"Eur Urol Focus"},{"issue":"4 Part B","key":"966_CR15","first-page":"E158","volume":"114","author":"SM Evans","year":"2012","unstructured":"Evans SM, Millar JL, Wood JM, Davis ID, Bolton D, Giles GG, et al. The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer. BJU Int. 2012;114(4 Part B):E158\u201366.","journal-title":"BJU Int"},{"issue":"5","key":"966_CR16","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.urology.2010.01.027","volume":"76","author":"KM Szymanski","year":"2010","unstructured":"Szymanski KM, Wei JT, Dunn RL, Sanda MG. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology. 2010;76(5):1245\u201350.","journal-title":"Urology"},{"key":"966_CR17","unstructured":"Australian Bureau of Statistics. Census of population and housing: socio-economic indexes for areas (SEIFA), Australia, 2016 Australia: ABS. 2016. Accessed 27 Aug 2019. https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/Lookup\/by%20Subject\/2033.0.55.001~2016~Main%20Features~IRSAD~20."},{"issue":"4","key":"966_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/bju.13380","volume":"118","author":"WL Ong","year":"2016","unstructured":"Ong WL, Evans SM, Spelman T, Kearns PA, Murphy DG, Millar JL. Comparison of oncological and health-related quality of life outcomes between open and robot-assisted radical prostatectomy for localised prostate cancer\u2014findings from the population-based Victorian Prostate Cancer Registry. BJU Int. 2016;118(4):563\u20139.","journal-title":"BJU Int"},{"issue":"6","key":"966_CR19","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","volume":"56","author":"JT Wei","year":"2000","unstructured":"Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899\u2013905.","journal-title":"Urology"},{"issue":"5","key":"966_CR20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/resp.12312","volume":"19","author":"EJ Williamson","year":"2014","unstructured":"Williamson EJ, Forbes A. Introduction to propensity scores. Respirology. 2014;19(5):625\u201335.","journal-title":"Respirology"},{"issue":"3","key":"966_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res"},{"issue":"8","key":"966_CR22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/jnci\/djw323","volume":"109","author":"XI Yao","year":"2017","unstructured":"Yao XI, Wang X, Speicher PJ, Hwang ES, Cheng P, Harpole DH, et al. Reporting and guidelines in propensity score analysis: a systematic review of cancer and cancer surgical studies. J Natl Cancer Inst. 2017;109(8):729.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"966_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.urology.2014.08.044","volume":"85","author":"TA Skolarus","year":"2015","unstructured":"Skolarus TA, Dunn RL, Sanda MG, Chang P, Greenfield TK, Litwin MS, et al. Minimally important difference for the expanded prostate cancer index composite short form. Urology. 2015;85(1):101\u20136.","journal-title":"Urology"},{"issue":"6","key":"966_CR24","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/jamasurg.2018.0647","volume":"153","author":"AH Kaji","year":"2018","unstructured":"Kaji AH, Rademaker AW, Hyslop T. Tips for analyzing large data sets from the JAMA surgery statistical editors. JAMA Surg. 2018;153(6):508\u20139.","journal-title":"JAMA Surg"},{"issue":"1","key":"966_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000496980","volume":"103","author":"A Antonelli","year":"2019","unstructured":"Antonelli A, Palumbo C, Noale M, Porreca A, Maggi S, Simeone C, et al. Impact of surgical approach on patient-reported outcomes after radical prostatectomy: a propensity score-weighted analysis from a multicenter, prospective, observational study (the pros-IT CNR study). Urol Int. 2019;103(1):8\u201318.","journal-title":"Urol Int"},{"issue":"8","key":"966_CR26","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/iju.12447","volume":"21","author":"KC Koo","year":"2014","unstructured":"Koo KC, Tuliao P, Yoon YE, Chung BH, Hong SJ, Yang SC, et al. Robot-assisted radical prostatectomy in the Korean population: a 5-year propensity-score matched comparative analysis versus open radical prostatectomy. Int J Urol. 2014;21(8):781\u20135.","journal-title":"Int J Urol"},{"issue":"2","key":"966_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.eururo.2017.04.027","volume":"73","author":"A Herlemann","year":"2018","unstructured":"Herlemann A, Cowan JE, Carroll PR, Cooperberg MR. Community-based outcomes of open versus robot-assisted radical prostatectomy. Eur Urol. 2018;73(2):215\u201323.","journal-title":"Eur Urol"},{"issue":"2","key":"966_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.eururo.2015.02.029","volume":"68","author":"E Haglind","year":"2015","unstructured":"Haglind E, Carlsson S, Stranne J, Wallerstedt A, Wilder\u00e4ng U, Thorsteinsdottir T, et al. Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled. Nonrand Trial Eur Urol. 2015;68(2):216\u201325.","journal-title":"Nonrand Trial Eur Urol"},{"issue":"4","key":"966_CR29","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eururo.2017.08.015","volume":"73","author":"P Sooriakumaran","year":"2018","unstructured":"Sooriakumaran P, Pini G, Nyberg T, Derogar M, Carlsson S, Stranne J, et al. Erectile function and oncologic outcomes following open retropubic and robot-assisted radical prostatectomy: results from the LAParoscopic prostatectomy robot open trial. Eur Urol. 2018;73(4):618\u201327.","journal-title":"Eur Urol"},{"issue":"2","key":"966_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.juro.2015.08.092","volume":"195","author":"B O'Neil","year":"2016","unstructured":"O\u2019Neil B, Koyama T, Alvarez J, Conwill RM, Albertsen PC, Cooperberg MR, et al. The comparative harms of open and robotic prostatectomy in population based samples. J Urol. 2016;195(2):321\u20139.","journal-title":"J Urol"},{"issue":"9","key":"966_CR31","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1089\/end.2017.0284","volume":"31","author":"MG Goldenberg","year":"2017","unstructured":"Goldenberg MG, Goldenberg L, Grantcharov TP. Surgeon performance predicts early continence after robot-assisted radical prostatectomy. J Endourol. 2017;31(9):858\u201363.","journal-title":"J Endourol"},{"issue":"9","key":"966_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.5694\/mja2.50794","volume":"213","author":"L Te Marvelde","year":"2020","unstructured":"Te Marvelde L, Milne RL, Hornby CJ, Chapman AB, Giles GG, Haines IE. Differences in treatment choices for localised prostate cancer diagnosed in private and public health services. Med J Aust. 2020;213(9):411\u20137.","journal-title":"Med J Aust"},{"issue":"8","key":"966_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.5694\/mja15.01041","volume":"204","author":"F Sampurno","year":"2016","unstructured":"Sampurno F, Earnest A, Kumari PB, Millar JL, Davis ID, Murphy DG, et al. Quality of care achievements of the prostate cancer outcomes registry-Victoria. Med J Aust. 2016;204(8):319.","journal-title":"Med J Aust"},{"key":"966_CR34","unstructured":"Victorian Cancer Registry. Cancer in Victoria: statistics & trends 2019. Cancer Council Victoria M, Victoria. Accessed 16 Dec 2020. 2020. https:\/\/www.cancervic.org.au\/research\/vcr\/publications."}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-022-00966-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-022-00966-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-022-00966-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T19:04:02Z","timestamp":1644260642000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-022-00966-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["966"],"URL":"https:\/\/doi.org\/10.1186\/s12894-022-00966-0","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]},"assertion":[{"value":"7 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was acquired from all participants of the study based on the recruitment strategy of the Prostate Cancer Outcomes Registry\u2014Victoria. This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Monash University Human Research Ethics Committee (ID: 19196) (Approval date: 17.05.2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DGM reports personal fees from Janssen Pharma, personal fees from Astellas Pharma, personal fees from Bayer Pharma, personal fees from Ferring, personal fees from Astra Zeneca, personal fees from Ipsen, outside the submitted work. No other authors report any conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}